Imexpharm Corp (IMP) — Financial Flexibility Index
Imexpharm Corp (IMP) has a Financial Flexibility Index of 0.12x as of June 2026. Free cash flow of ₫72.65 Billion (operating CF ₫55.75 Billion minus capex ₫16.90 Billion) represents 0% of total liabilities (₫605.60 Billion). Check cash flow reinvestment rate of Imexpharm Corp to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Imexpharm Corp Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Imexpharm Corp across 7 annual periods. For the full cash flow conversion analysis, see IMP cash generation efficiency.
Annual Financial Flexibility Index for Imexpharm Corp (2019–2025)
Year-by-year free cash flow to debt coverage for Imexpharm Corp. Explore how well can Imexpharm Corp service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (VND) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | ₫81.05 Billion | ₫54.17 Billion | ₫476.11 Billion | ▼ -82.5% |
| 2024 | 0.97x | ₫313.04 Billion | ₫216.27 Billion | ₫321.66 Billion | ▲ +1225.1% |
| 2023 | 0.07x | ₫22.62 Billion | ₫-40.47 Billion | ₫308.04 Billion | ▼ -94.1% |
| 2022 | 1.25x | ₫477.96 Billion | ₫378.60 Billion | ₫382.50 Billion | ▲ +117.3% |
| 2021 | 0.58x | ₫287.74 Billion | ₫234.88 Billion | ₫500.29 Billion | ▲ +29.3% |
| 2020 | 0.44x | ₫162.84 Billion | ₫73.15 Billion | ₫365.97 Billion | ▼ -35.1% |
| 2019 | 0.69x | ₫197.72 Billion | ₫66.59 Billion | ₫288.29 Billion | — |